ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/053/SRR13131453/SRR13131453_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/055/SRR13131455/SRR13131455_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/057/SRR13131457/SRR13131457_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/056/SRR13131456/SRR13131456_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/054/SRR13131454/SRR13131454_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/058/SRR13131458/SRR13131458_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/057/SRR13131457/SRR13131457_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/060/SRR13131460/SRR13131460_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/060/SRR13131460/SRR13131460_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/052/SRR13131452/SRR13131452_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/054/SRR13131454/SRR13131454_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/053/SRR13131453/SRR13131453_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/059/SRR13131459/SRR13131459_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/052/SRR13131452/SRR13131452_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/058/SRR13131458/SRR13131458_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/055/SRR13131455/SRR13131455_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/059/SRR13131459/SRR13131459_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR131/056/SRR13131456/SRR13131456_2.fastq.gzprimaryOK200GenomicsHuazhong university of science and technologyhttps://www.ebi.ac.uk/ena/browser/view/PRJNA680664Nucleostemin(NS) promotes CRC cancer cells metastasisENAClr, Malignant Neoplasm, Metastasis, E2-induced gene 3 protein, Nucleostemin, SCRIB1, Neoplasms, potp, Metastases, Benign Neoplasm, Neoplasm Metastases, eth, neoplasm metastasis, Tumor, F20O9_210, Malignant, autosomal dominant, Cell, cancer metastasis, Metastase, colorectal cancer, MT, Benign, dATF-4, Neoplasm, anon-EST:Liang-2.17, Novel nucleolar protein 47, Crc, anon-EST:Liang-2.11, CRC, clone 2.11, l(2)crc, anon-EST:fe3D7, Atf4, 929, DmelCG8669, large bowel cancer, tumor cell migration, cruciferin 3, primary cancer, Malignancy, Metastases., clone 2.17, susceptibility to, Scrb1, CG9429, F20O9.210, Benign Neoplasms, crc, metastasis, CRUCIFERIN C, CRIB, Ire1, Cancers, cancer of large bowel, malignant tumor, large intestine cancer, Malignant Neoplasms, cancer of the large intestine, ATF-4, Neoplasias, DmelCG9429, crt, colon cancer, malignant neoplasm, Nucleolar GTP-binding protein 3, vartul, cancer of the large bowel, CG8669, Malignancies, cancer of large intestine, mKIAA0147, ATF4/crc, tumor metastasis, NNP47, somatic mutation, Neoplasia, AI118201, colorectal (colon or rectal) cancer, Cancer, TumorsfalseNucleostemin promotes CRC cancer cells metastasis2023-05-192021-12-02PRJNA680664